• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    43.28 Down 1.31(2.94%) Jun 24, 4:00PM EDT
    |After Hours : 43.28 0.00 (0.00%) Jun 24, 5:23PM EDT
    Prev Close:44.59
    Open:42.20
    Bid:41.00 x 500
    Ask:70.00 x 400
    1y Target Est:68.25
    Beta:-0.027225
    Earnings Date:Jul 27 - Aug 1 (Est.)
    Day's Range:41.56 - 44.71
    52wk Range:31.25 - 58.46
    Volume:8,931,812
    Avg Vol (3m):1,161,740
    Market Cap:3.75B
    P/E (ttm):N/A
    EPS (ttm):-1.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXDown 2.94%3.75B
    LLYUp 0.53%78.44B
    PFEDown 1.79%206.02B
    ABTDown 4.34%55.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):257.60
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-16) :-1.95
    Quarterly EPS Est (Jun-16) :-0.49
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):2.49

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback